{
  "documents": [
    {
      "id": "cluster_27_doc1",
      "content": "The claims audit for Q3 highlighted an increase in prior authorization requests for biologics at Mountain View Regional. Dr. Elara Koshy noted a 28% rise in rheumatology referrals, particularly for psoriatic arthritis patients. The audit flagged Policy #BIOL-441 revisions requiring step therapy attempts before biologic approvals. Systems memo attached shows data integration gaps between Epic and the regional provider network portal.",
      "metadata": {
        "format": "audit_report"
      }
    },
    {
      "id": "cluster_27_doc2",
      "content": "Patient 88742-LZW (DOB 04/15/1987) presented with persistent dactylitis and nail pitting at Banner Arthritis Center. Initial treatment plan included methotrexate + prednisone taper. Prior auth submitted for TNF inhibitor under exception criteria per Policy #BIOL-441. Provider phone: 602-555-0187. Next follow-up scheduled 12 weeks post-treatment initiation.",
      "metadata": {
        "format": "medical_record"
      }
    },
    {
      "id": "cluster_27_doc3",
      "content": "Mountain View Rheumatology quarterly review shows 62% of psoriatic arthritis patients required therapy adjustments within first 3 months. Research collaboration with Banner initiated to track outcomes of Policy #BIOL-441 implementation. Study ID: ARTH-339. Contact research coordinator at rcoordinators@bannerarth.edu for participation details.",
      "metadata": {
        "format": "research_note"
      }
    },
    {
      "id": "cluster_27_doc4",
      "content": "Patient survey response from 88742-LZW: 'Medication prior authorization process took 11 days, delaying my treatment. Dr. Koshy’s team eventually secured approval for monthly injections.' Address: 4427 Silverado Trail, Fountain Hills, AZ. Survey submitted via portal on 10/22/2023.",
      "metadata": {
        "format": "patient_survey"
      }
    },
    {
      "id": "cluster_27_doc5",
      "content": "Phoenix Healthcare Journal reports Mountain View Regional testing new prior authorization AI platform targeting rheumatology claims. Pilot reduced decision time by 40% for Policy #BIOL-441 cases. Implementation challenges include EHR mapping discrepancies and staff training needs. Full rollout expected Q2 2024.",
      "metadata": {
        "format": "news_article"
      }
    }
  ],
  "metadata": {
    "category": "cluster",
    "cluster_id": "cluster_27",
    "cluster_risk": "MEDIUM",
    "content_summary": "Psoriatic arthritis treatment journey involving biologic prior authorization under Policy #BIOL-441, with connections between patient care, provider network challenges, and research study ARTH-339",
    "person": {
      "entities": [
        [
          "88742-LZW",
          "PATIENT_ID"
        ],
        [
          "04/15/1987",
          "BIRTHDATE"
        ],
        [
          "4427 Silverado Trail, Fountain Hills, AZ",
          "ADDRESS"
        ],
        [
          "psoriatic arthritis",
          "MEDICAL_CONDITION"
        ],
        [
          "dactylitis",
          "MEDICAL_CONDITION"
        ],
        [
          "methotrexate",
          "TREATMENT"
        ],
        [
          "prednisone taper",
          "TREATMENT"
        ],
        [
          "TNF inhibitor",
          "TREATMENT"
        ],
        [
          "Mountain View Regional",
          "LOCATION"
        ],
        [
          "Banner Arthritis Center",
          "PROVIDER"
        ],
        [
          "Dr. Elara Koshy",
          "PROVIDER"
        ]
      ]
    },
    "questions": [
      {
        "q": "What new AI implementation reduced decision times for Policy #BIOL-441 rheumatology claims?",
        "a": "Mountain View Regional's prior authorization AI platform reduced decision time by 40%.",
        "sources": [
          "cluster_27_doc5"
        ],
        "type": "specific"
      },
      {
        "q": "What percentage of rheumatology referrals increased at Mountain View Regional?",
        "a": "Dr. Elara Koshy noted a 28% rise in rheumatology referrals.",
        "sources": [
          "cluster_27_doc1"
        ],
        "type": "general"
      },
      {
        "q": "Which treatments were prescribed and what was the patient’s experience regarding prior authorization for patient 88742-LZW through Banner Arthritis Center under Policy #BIOL-441?",
        "a": "Methotrexate + prednisone taper; prior authorization took 11 days.",
        "sources": [
          "cluster_27_doc2",
          "cluster_27_doc4"
        ],
        "type": "specific"
      },
      {
        "q": "What challenges were reported during Policy #BIOL-441 implementation across documents?",
        "a": "Data integration gaps and EHR mapping discrepancies.",
        "sources": [
          "cluster_27_doc1",
          "cluster_27_doc5"
        ],
        "type": "general"
      }
    ]
  }
}